𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of abciximab versus tirofiban on activated clotting time during percutaneous intervention and its relation to clinical outcomes—observations from the TARGET trial

✍ Scribed by Ivan P Casserly; Eric J Topol; Gang Jia; Richard A Lange; Christian Hamm; Bernhard Meier; Peter M DiBattiste; Nasser Lakkis; Derek P Chew; Gregg W Stone; David J Cohen; David J Moliterno


Book ID
113976743
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
186 KB
Volume
92
Category
Article
ISSN
0002-9149

No coin nor oath required. For personal study only.